Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study
We evaluated treatment outcomes of external beam radiation therapy (EBRT) for unresectable locally advanced thyroid cancer (LATC) with or without metastasis. We enrolled 11 LATC patients who underwent EBRT (median age: 76 (45–83) years; six males and five females). Eastern Cooperative Oncology Group...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Series: | Radiation |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-592X/1/3/16 |
| _version_ | 1797517414064193536 |
|---|---|
| author | Yuki Wada Akira Anbai Satoshi Kumagai Eriko Okuyama Noriko Takagi Manabu Hashimoto |
| author_facet | Yuki Wada Akira Anbai Satoshi Kumagai Eriko Okuyama Noriko Takagi Manabu Hashimoto |
| author_sort | Yuki Wada |
| collection | DOAJ |
| description | We evaluated treatment outcomes of external beam radiation therapy (EBRT) for unresectable locally advanced thyroid cancer (LATC) with or without metastasis. We enrolled 11 LATC patients who underwent EBRT (median age: 76 (45–83) years; six males and five females). Eastern Cooperative Oncology Group performance statuses of 0 (<i>n</i> = 3), 1 (<i>n</i> = 1), 2 (<i>n</i> = 6), and 3 (<i>n</i> = 1) were observed. Histologic types included papillary carcinoma (<i>n</i> = 5), anaplastic carcinoma (<i>n</i> = 3), and squamous cell carcinoma (<i>n</i> = 3). The organs invaded by the tumor that caused it to be deemed unresectable were common carotid artery (<i>n</i> = 5), trachea (<i>n</i> = 4), aorta (<i>n</i> = 1) and larynx (<i>n</i> = 1). The median follow-up time was 6 months. One, seven, two, and one patient showed complete response (CR), partial response (PR), stable disease, and progressive disease, respectively. The rate of local CR+PR was 73%; moreover, 75% of patients achieved a >30% tumor size reduction within 6 months. The median local progression-free survival of patients with local CR+PR was 11.5 (4–68) months. The median overall survival was 6 (1–68) months. Grade 3 acute complications occurred in five (45%) patients. No patients had Grade 4 or 5 complications. In conclusion, EBRT reduced the tumor volume in 75% of LATC patients without inducing severe toxicity. This therapy should be considered as a treatment option for LATC. |
| first_indexed | 2024-03-10T07:16:17Z |
| format | Article |
| id | doaj.art-468bbab905f8450b8c3d017232380ecc |
| institution | Directory Open Access Journal |
| issn | 2673-592X |
| language | English |
| last_indexed | 2024-03-10T07:16:17Z |
| publishDate | 2021-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Radiation |
| spelling | doaj.art-468bbab905f8450b8c3d017232380ecc2023-11-22T15:02:22ZengMDPI AGRadiation2673-592X2021-07-011317418210.3390/radiation1030016Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center StudyYuki Wada0Akira Anbai1Satoshi Kumagai2Eriko Okuyama3Noriko Takagi4Manabu Hashimoto5Department of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanDepartment of Radiology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, JapanWe evaluated treatment outcomes of external beam radiation therapy (EBRT) for unresectable locally advanced thyroid cancer (LATC) with or without metastasis. We enrolled 11 LATC patients who underwent EBRT (median age: 76 (45–83) years; six males and five females). Eastern Cooperative Oncology Group performance statuses of 0 (<i>n</i> = 3), 1 (<i>n</i> = 1), 2 (<i>n</i> = 6), and 3 (<i>n</i> = 1) were observed. Histologic types included papillary carcinoma (<i>n</i> = 5), anaplastic carcinoma (<i>n</i> = 3), and squamous cell carcinoma (<i>n</i> = 3). The organs invaded by the tumor that caused it to be deemed unresectable were common carotid artery (<i>n</i> = 5), trachea (<i>n</i> = 4), aorta (<i>n</i> = 1) and larynx (<i>n</i> = 1). The median follow-up time was 6 months. One, seven, two, and one patient showed complete response (CR), partial response (PR), stable disease, and progressive disease, respectively. The rate of local CR+PR was 73%; moreover, 75% of patients achieved a >30% tumor size reduction within 6 months. The median local progression-free survival of patients with local CR+PR was 11.5 (4–68) months. The median overall survival was 6 (1–68) months. Grade 3 acute complications occurred in five (45%) patients. No patients had Grade 4 or 5 complications. In conclusion, EBRT reduced the tumor volume in 75% of LATC patients without inducing severe toxicity. This therapy should be considered as a treatment option for LATC.https://www.mdpi.com/2673-592X/1/3/16external beam radiation therapylocally advanced thyroid cancertyrosine kinase inhibitorsquamous cell thyroid cancer |
| spellingShingle | Yuki Wada Akira Anbai Satoshi Kumagai Eriko Okuyama Noriko Takagi Manabu Hashimoto Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study Radiation external beam radiation therapy locally advanced thyroid cancer tyrosine kinase inhibitor squamous cell thyroid cancer |
| title | Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study |
| title_full | Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study |
| title_fullStr | Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study |
| title_full_unstemmed | Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study |
| title_short | Treatment Outcomes of External Beam Radiation Therapy for Unresectable Locally Advanced Thyroid Cancer with or without Metastasis: A Retrospective Single-Center Study |
| title_sort | treatment outcomes of external beam radiation therapy for unresectable locally advanced thyroid cancer with or without metastasis a retrospective single center study |
| topic | external beam radiation therapy locally advanced thyroid cancer tyrosine kinase inhibitor squamous cell thyroid cancer |
| url | https://www.mdpi.com/2673-592X/1/3/16 |
| work_keys_str_mv | AT yukiwada treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy AT akiraanbai treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy AT satoshikumagai treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy AT erikookuyama treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy AT norikotakagi treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy AT manabuhashimoto treatmentoutcomesofexternalbeamradiationtherapyforunresectablelocallyadvancedthyroidcancerwithorwithoutmetastasisaretrospectivesinglecenterstudy |